European guidelines on perinatal care- Peripartum care Episiotomy.

OF RECOMMENDATIONS1. Episiotomy should be performed by indication only, and not routinely (. Accepted indications for episiotomy are to shorten the second stage of labor when there is suspected fetal hypoxia ; to prevent obstetric anal sphincter injury in vaginal operative deliveries, or when obstetric sphincter injury occurred in previous deliveries (2.

Pelvic congestion syndrome (PCS) as a pathology of postmenopausal women: a case report with literature review.

Background: Due to the scarcity of adequately powered, randomized controlled trials and internationally standardized diagnostic criteria, evidence on the diagnosis and treatment of pelvic congestion syndrome (PCS) is limited. Earlier epidemiologic observations led to the attribution of PCS to the premenopausal state, and a remission of symptoms after menopause is frequently described a hallmark of the pathology. This concept has currently been challenged by radiological studies reporting a notable prevalence of ovarian venous congestion in adult female patients of advanced age.

Health behaviour and attitude towards screening examinations in an Austrian urban and rural population: gender aspects - screening and sex.

Background: Both sexes are at different risks for cancers and gender-dependent fears and barriers might influence their attitude towards screening. The aim of the present study was to assess gender issues in demographic variables which could influence the use of screening examinations.

Methods: A standardized questionnaire was used to assess data of 513 Austrians, with urban and rural location of residence, aged 35-65 years.

Breech presentation: a retrospective analysis of 12-years' experience at a single center.

Objective: To investigate neonatal outcome after breech presentation in term pregnancies.

Study Design: Data from 1345 term breech deliveries over a 12-year study period were retrospectively reviewed. Neonatal morbidity and mortality were compared by route of delivery.

Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.

Background: Clinical trial data have shown that among breast cancer patients who were disease free after 5 years of adjuvant treatment with tamoxifen, further extended treatment with the nonsteroidal aromatase inhibitor letrozole reduces breast cancer recurrence. We examined the efficacy and tolerability of extended adjuvant therapy with another aromatase inhibitor, anastrozole, for 3 years among women who had completed 5 years of adjuvant therapy.

Methods: Austrian Breast and Colorectal Cancer Study Group (ABCSG) Trial 6a is an extension of ABCSG Trial 6, in which hormone receptor-positive postmenopausal patients received 5 years of adjuvant tamoxifen, with or without the aromatase inhibitor aminoglutethimide, for the first 2 years of therapy.